首页> 外文期刊>International reviews of immunology >CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
【24h】

CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.

机译:CD19,CD21和CD22:B淋巴细胞信号转导的多方面反应调节剂。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

B lymphocyte development and function depend upon the activity of intrinsic and B cell antigen receptor (BCR)-induced signals. These signals are interpreted, amplified, fine-tuned, or suppressed through the precise actions of specialized cell surface coreceptors, or "response regulators," that inform B cells of their extracellular environment. Important cell surface response regulators include the CD19/CD21 complex, CD22, and CD72. CD19 establishes a novel Src-family protein tyrosine kinase (PTK) amplification loop that regulates basal signaling thresholds and intensifies Src-family PTK activation following BCR ligation. In turn, CD22 limits the intensity of CD19-dependent, BCR-generated signals through the recruitment of potent phosphotyrosine and phosphoinositide phosphatases. Herein we discuss our current understanding of how CD19/CD21 and CD22 govern the emergence and intensity of BCR-mediated signals, and how alterations in these tightly controlled regulatory activities contribute to autoimmunity in mice and humans.
机译:B淋巴细胞的发育和功能取决于内在和B细胞抗原受体(BCR)诱导的信号的活性。这些信号通过专门的细胞表面共受体或“反应调节剂”的精确作用来解释,放大,微调或抑制,这些信号将B细胞告知其细胞外环境。重要的细胞表面反应调节剂包括CD19 / CD21复合物,CD22和CD72。 CD19建立了一个新的Src家族蛋白酪氨酸激酶(PTK)扩增环,该环可调节基本信号阈值并在BCR连接后增强Src家族PTK的激活。反过来,CD22通过募集有效的磷酸酪氨酸和磷酸肌醇磷酸酶来限制CD19依赖性BCR产生的信号的强度。在这里,我们讨论了我们目前对CD19 / CD21和CD22如何控制BCR介导信号的出现和强度以及这些严格控制的调节活动中的改变如何促进小鼠和人类自身免疫的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号